Fundz

BIOPHTA secures €6.5M in Seed funding led by UI Investissement, Elaia, and GO Capital to develop breakthrough technology for the treatment of eye diseases

PRIVATEJun 03, 2024

Amount Raised

€6.5 Million

Round Type

Seed

ParisBiotechnologyHealth Care

Investors

Htl BiotechnologyUnither PharmaceuticalsGO CapitalElaiaUI Investissement

Description

BIOPHTA, a preclinical biotech company, has secured €6.5 million in Seed funding to bring its patented technology for the treatment of eye diseases to clinical development. The funding will be used for the clinical validation of its technology in treating Glaucoma and Macular Edema.

Quick answer

BIOPHTA raised €6.5 Million in a Seed round, dated June 3, 2024. Investors: Htl Biotechnology, Unither Pharmaceuticals, GO Capital, Elaia and UI Investissement. BIOPHTA is based in Paris, Ile-de-France, France.

How much did BIOPHTA raise?
BIOPHTA raised €6.5 Million in a Seed round on June 3, 2024.
Who invested in BIOPHTA?
Htl Biotechnology, Unither Pharmaceuticals, GO Capital, Elaia and UI Investissement are named as investors in this round.
What does BIOPHTA do?
BIOPHTA is a preclinical biotech company developing technology for the treatment of eye diseases.
Where is BIOPHTA based and how big is it?
BIOPHTA is based in Paris, Ile-de-France, France.
Who are the decision-makers at BIOPHTA?
Fundz holds 1 contact at BIOPHTA. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology and Health Care around the same time

Companies in the same sectors as BIOPHTA that raised within 45 days of this round, from Fundz verified event records.

  • GRO Biosciences raised $27M on July 18, 2024.
  • Novocuff raised $26M (Series A) on July 17, 2024.
  • Renalys Pharma raised $38M (Series A) on July 17, 2024.
  • Loci Orthopaedics raised $14M (Series A) on July 17, 2024.
  • NGM Bio raised $122M (Series A) on July 17, 2024.
  • Truvian Health raised $74M (Funding Round) on July 17, 2024.

Who to call at BIOPHTA, and when

A new round usually means BIOPHTA is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day BIOPHTA raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at BIOPHTA, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at BIOPHTA. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

BIOPHTA

Location

Paris, Ile-de-France, France

About

BIOPHTA is a preclinical biotech company developing technology for the treatment of eye diseases. It has received several awards for its innovative work and is currently targeting the two leading causes of blindness worldwide.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment BIOPHTA raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for BIOPHTA's next move

See what Strategic adds

BIOPHTA raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.